NVO: Novo Nordisk A S Financial Statements
Balance sheet, income statement, and cash flow statements for Novo Nordisk A S (NVO).
$387.95B Market Cap.
NVO Market Cap. (MRY)
NVO Shares Outstanding (MRY)
NVO Assets (MRY)
Total Assets
$465.80B
Total Liabilities
$322.31B
Total Investments
$13.33B
NVO Income (MRY)
Revenue
$290.40B
Net Income
$100.99B
Operating Expense
$117.54B
NVO Cash Flow (MRY)
CF Operations
$120.97B
CF Investing
-$128.90B
CF Financing
$8.73B
NVO Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $465,795,000,000 (48.11%) | $314,486,000,000 (30.35%) | $241,257,000,000 (24.03%) | $194,508,000,000 (34.22%) |
Assets Current | $160,897,000,000 (15.22%) | $139,646,000,000 (29.07%) | $108,194,000,000 (26.40%) | $85,595,000,000 (30.07%) |
Assets Non-Current | $304,898,000,000 (74.39%) | $174,840,000,000 (31.40%) | $133,063,000,000 (22.17%) | $108,913,000,000 (37.67%) |
Goodwill & Intangible Assets | $111,090,000,000 (83.91%) | $60,406,000,000 (18.58%) | $50,939,000,000 (17.99%) | $43,171,000,000 (108.99%) |
Shareholders Equity | $143,486,000,000 (34.65%) | $106,561,000,000 (27.64%) | $83,486,000,000 (18.01%) | $70,746,000,000 (11.72%) |
Property Plant & Equipment Net | $162,488,000,000 (78.63%) | $90,961,000,000 (36.43%) | $66,671,000,000 (20.43%) | $55,362,000,000 (10.13%) |
Cash & Equivalents | $15,655,000,000 (8.78%) | $14,392,000,000 (13.74%) | $12,653,000,000 (18.03%) | $10,720,000,000 (-15.97%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $13,330,000,000 (-23.83%) | $17,501,000,000 (42.70%) | $12,264,000,000 (49.45%) | $8,206,000,000 (397.94%) |
Investments Current | $10,653,000,000 (-32.74%) | $15,838,000,000 (45.02%) | $10,921,000,000 (61.43%) | $6,765,000,000 (0%) |
Investments Non-Current | $2,677,000,000 (60.97%) | $1,663,000,000 (23.83%) | $1,343,000,000 (-6.80%) | $1,441,000,000 (-12.56%) |
Inventory | $40,849,000,000 (28.41%) | $31,811,000,000 (30.44%) | $24,388,000,000 (24.30%) | $19,621,000,000 (5.85%) |
Trade & Non-Trade Receivables | $71,949,000,000 (11.08%) | $64,770,000,000 (28.11%) | $50,560,000,000 (24.40%) | $40,643,000,000 (46.55%) |
Trade & Non-Trade Payables | $28,846,000,000 (12.65%) | $25,606,000,000 (64.28%) | $15,587,000,000 (75.73%) | $8,870,000,000 (55.15%) |
Accumulated Retained Earnings (Deficit) | $144,448,000,000 (37.78%) | $104,839,000,000 (30.09%) | $80,587,000,000 (11.92%) | $72,004,000,000 (12.90%) |
Tax Assets | $27,480,000,000 (20.51%) | $22,803,000,000 (53.62%) | $14,844,000,000 (51.61%) | $9,791,000,000 (59.10%) |
Tax Liabilities | $15,142,000,000 (-12.36%) | $17,278,000,000 (22.09%) | $14,152,000,000 (58.49%) | $8,929,000,000 (39.19%) |
Total Debt | $102,787,000,000 (280.61%) | $27,006,000,000 (4.74%) | $25,784,000,000 (-3.23%) | $26,645,000,000 (157.29%) |
Debt Current | $13,113,000,000 (102.42%) | $6,478,000,000 (341.88%) | $1,466,000,000 (-89.29%) | $13,684,000,000 (83.46%) |
Debt Non-Current | $89,674,000,000 (336.84%) | $20,528,000,000 (-15.59%) | $24,318,000,000 (87.62%) | $12,961,000,000 (347.39%) |
Total Liabilities | $322,309,000,000 (55.01%) | $207,925,000,000 (31.79%) | $157,771,000,000 (27.48%) | $123,762,000,000 (51.67%) |
Liabilities Current | $217,528,000,000 (28.22%) | $169,655,000,000 (40.28%) | $120,940,000,000 (21.53%) | $99,516,000,000 (41.61%) |
Liabilities Non-Current | $104,781,000,000 (173.79%) | $38,270,000,000 (3.91%) | $36,831,000,000 (51.91%) | $24,246,000,000 (114.11%) |
NVO Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $290,403,000,000 (25.03%) | $232,261,000,000 (31.26%) | $176,954,000,000 (25.68%) | $140,800,000,000 (10.91%) |
Cost of Revenue | $44,522,000,000 (24.48%) | $35,765,000,000 (25.72%) | $28,448,000,000 (20.25%) | $23,658,000,000 (13.02%) |
Selling General & Administrative Expense | $67,377,000,000 (9.38%) | $61,598,000,000 (21.53%) | $50,684,000,000 (23.44%) | $41,058,000,000 (11.31%) |
Research & Development Expense | $48,062,000,000 (48.14%) | $32,443,000,000 (34.91%) | $24,047,000,000 (35.31%) | $17,772,000,000 (14.94%) |
Operating Expenses | $117,542,000,000 (25.15%) | $93,922,000,000 (27.44%) | $73,697,000,000 (25.98%) | $58,498,000,000 (12.74%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $26,203,000,000 (24.83%) | $20,991,000,000 (55.06%) | $13,537,000,000 (19.55%) | $11,323,000,000 (3.01%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | $100,988,000,000 (20.68%) | $83,683,000,000 (50.71%) | $55,525,000,000 (16.27%) | $47,757,000,000 (13.33%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | $100,988,000,000 (20.68%) | $83,683,000,000 (50.71%) | $55,525,000,000 (16.27%) | $47,757,000,000 (13.33%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | $100,988,000,000 (20.68%) | $83,683,000,000 (50.71%) | $55,525,000,000 (16.27%) | $47,757,000,000 (13.33%) |
Weighted Average Shares | $4,510,000,000 (-1.10%) | $4,560,000,000 (0.81%) | $4,523,200,000 (-1.32%) | $4,583,800,000 (-2.80%) |
Weighted Average Shares Diluted | - | - | - | - |
Earning Before Interest & Taxes (EBIT) | $127,191,000,000 (21.51%) | $104,674,000,000 (51.57%) | $69,062,000,000 (16.90%) | $59,080,000,000 (11.20%) |
Gross Profit | $245,881,000,000 (25.13%) | $196,496,000,000 (32.32%) | $148,506,000,000 (26.77%) | $117,142,000,000 (10.50%) |
Operating Income | $128,339,000,000 (25.12%) | $102,574,000,000 (37.11%) | $74,809,000,000 (27.56%) | $58,644,000,000 (8.35%) |
NVO Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | -$128,895,000,000 (-193.66%) | -$43,892,000,000 (-76.15%) | -$24,918,000,000 (21.16%) | -$31,605,000,000 (-40.87%) |
Net Cash Flow from Financing | $8,735,000,000 (113.83%) | -$63,158,000,000 (-21.93%) | -$51,797,000,000 (-103.18%) | -$25,493,000,000 (20.94%) |
Net Cash Flow from Operations | $120,968,000,000 (11.07%) | $108,908,000,000 (38.06%) | $78,887,000,000 (43.43%) | $55,000,000,000 (5.87%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $1,263,000,000 (-27.37%) | $1,739,000,000 (-10.08%) | $1,934,000,000 (228.33%) | -$1,507,000,000 (52.68%) |
Net Cash Flow - Business Acquisitions and Disposals | -$82,163,000,000 (0%) | $0 (0%) | -$7,075,000,000 (61.29%) | -$18,279,000,000 (-4787.43%) |
Net Cash Flow - Investment Acquisitions and Disposals | $4,577,000,000 (191.61%) | -$4,996,000,000 (-61.68%) | -$3,090,000,000 (47.99%) | -$5,941,000,000 (-49608.33%) |
Capital Expenditure | -$47,164,000,000 (-82.76%) | -$25,806,000,000 (-112.47%) | -$12,146,000,000 (-91.73%) | -$6,335,000,000 (-8.89%) |
Issuance (Repayment) of Debt Securities | $73,056,000,000 (5079.96%) | -$1,467,000,000 (39.08%) | -$2,408,000,000 (-115.56%) | $15,471,000,000 (226.94%) |
Issuance (Purchase) of Equity Shares | -$20,181,000,000 (32.56%) | -$29,924,000,000 (-24.24%) | -$24,086,000,000 (-23.85%) | -$19,447,000,000 (-15.38%) |
Payment of Dividends & Other Cash Distributions | -$44,140,000,000 (-38.95%) | -$31,767,000,000 (-25.55%) | -$25,303,000,000 (-17.60%) | -$21,517,000,000 (-6.94%) |
Effect of Exchange Rate Changes on Cash | $455,000,000 (482.35%) | -$119,000,000 (50.00%) | -$238,000,000 (-140.27%) | $591,000,000 (229.61%) |
Share Based Compensation | - | - | $0 (0%) | $0 (0%) |
Depreciation Amortization & Accretion | $19,107,000,000 (102.99%) | $9,413,000,000 (27.86%) | $7,362,000,000 (22.19%) | $6,025,000,000 (4.73%) |
NVO Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 84.70% (0.12%) | 84.60% (0.83%) | 83.90% (0.84%) | 83.20% (-0.36%) |
Profit Margin | 34.80% (-3.33%) | 36.00% (14.65%) | 31.40% (-7.37%) | 33.90% (2.11%) |
EBITDA Margin | 50.40% (2.65%) | 49.10% (13.66%) | 43.20% (-6.49%) | 46.20% (-0.43%) |
Return on Average Equity (ROAE) | 85.00% (-6.08%) | 90.50% (22.80%) | 73.70% (0.68%) | 73.20% (3.10%) |
Return on Average Assets (ROAA) | 26.40% (-9.59%) | 29.20% (18.22%) | 24.70% (-13.64%) | 28.60% (-7.14%) |
Return on Sales (ROS) | 43.80% (-2.88%) | 45.10% (15.64%) | 39.00% (-7.14%) | 42.00% (0.24%) |
Return on Invested Capital (ROIC) | 87.20% (-33.18%) | 130.50% (33.85%) | 97.50% (-7.41%) | 105.30% (-8.99%) |
Dividend Yield | 1.70% (70.00%) | 1.00% (-16.67%) | 1.20% (-7.69%) | 1.30% (-31.58%) |
Price to Earnings Ratio (P/E) | 27.21 (-27.26%) | 37.4 (-2.36%) | 38.31 (7.79%) | 35.54 (50.55%) |
Price to Sales Ratio (P/S) | 9.58 (-30.14%) | 13.71 (14.21%) | 12 (-0.23%) | 12.03 (52.03%) |
Price to Book Ratio (P/B) | 19.39 (-35.12%) | 29.88 (17.44%) | 25.44 (6.25%) | 23.95 (50.94%) |
Debt to Equity Ratio (D/E) | 2.25 (15.12%) | 1.95 (3.23%) | 1.89 (8.06%) | 1.75 (35.69%) |
Earnings Per Share (EPS) | 22.67 (21.42%) | 18.67 (52.28%) | 12.26 (17.88%) | 10.4 (15.24%) |
Sales Per Share (SPS) | 8.98 (19.02%) | 7.55 (33.87%) | 5.64 (21.12%) | 4.65 (5.46%) |
Free Cash Flow Per Share (FCFPS) | 16.36 (-10.20%) | 18.22 (23.51%) | 14.76 (38.98%) | 10.62 (8.52%) |
Book Value Per Share (BVPS) | 31.82 (36.14%) | 23.37 (26.61%) | 18.46 (19.59%) | 15.43 (14.94%) |
Tangible Assets Book Value Per Share (TABVPS) | 78.65 (41.15%) | 55.72 (32.42%) | 42.08 (27.44%) | 33.02 (25.29%) |
Enterprise Value Over EBIT (EV/EBIT) | 22 (-26.67%) | 30 (-3.23%) | 31 (10.71%) | 28 (47.37%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 19.01 (-31.80%) | 27.88 (0.41%) | 27.77 (7.73%) | 25.77 (54.18%) |
Asset Turnover | 0.76 (-6.54%) | 0.81 (3.18%) | 0.79 (-6.76%) | 0.84 (-9.16%) |
Current Ratio | 0.74 (-10.09%) | 0.82 (-8.04%) | 0.9 (4.07%) | 0.86 (-8.12%) |
Dividends | $1.44 (39.19%) | $1.04 (27.90%) | $0.81 (7.57%) | $0.75 (15.49%) |
Free Cash Flow (FCF) | $73,804,000,000 (-11.19%) | $83,102,000,000 (24.51%) | $66,741,000,000 (37.14%) | $48,665,000,000 (5.49%) |
Enterprise Value (EV) | $387,943,590,805 (-17.67%) | $471,218,913,229 (54.12%) | $305,754,785,270 (20.27%) | $254,232,643,750 (57.56%) |
Earnings Before Tax (EBT) | $127,191,000,000 (21.51%) | $104,674,000,000 (51.57%) | $69,062,000,000 (16.90%) | $59,080,000,000 (11.20%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $146,298,000,000 (28.23%) | $114,087,000,000 (49.28%) | $76,424,000,000 (17.39%) | $65,105,000,000 (10.57%) |
Invested Capital | $224,309,000,000 (131.15%) | $97,039,000,000 (17.61%) | $82,509,000,000 (21.79%) | $67,746,000,000 (31.31%) |
Working Capital | -$56,631,000,000 (-88.71%) | -$30,009,000,000 (-135.44%) | -$12,746,000,000 (8.44%) | -$13,921,000,000 (-211.85%) |
Tangible Asset Value | $354,705,000,000 (39.60%) | $254,080,000,000 (33.50%) | $190,318,000,000 (25.76%) | $151,337,000,000 (21.79%) |
Market Capitalization | $387,950,200,000 (-17.76%) | $471,732,000,000 (54.12%) | $306,084,944,000 (19.24%) | $256,692,800,000 (55.86%) |
Average Equity | $118,860,250,000 (28.53%) | $92,474,750,000 (22.82%) | $75,292,000,000 (15.43%) | $65,228,250,000 (9.93%) |
Average Assets | $382,885,000,000 (33.72%) | $286,341,250,000 (27.24%) | $225,039,250,000 (34.74%) | $167,018,500,000 (22.08%) |
Invested Capital Average | $145,837,250,000 (81.77%) | $80,232,000,000 (13.28%) | $70,825,750,000 (26.24%) | $56,102,250,000 (22.16%) |
Shares | 4,510,000,000 (-1.10%) | 4,560,000,000 (0.81%) | 4,523,200,000 (-1.32%) | 4,583,800,000 (-2.80%) |